Progesterone Decreases in vitro Indoleamine 2, 3-dioxygenase Expression in Dendritic and CD4⁺ Cells from Maternal-Fetal Interface of Rats

References

• Alecsandru D, García-Velasco JA. 2015. Immunology and human reproduction. Curr Opin Obstet Gynecol, 27, 231–234.
   PubMed Web of Science ®Google Scholar
• Ball HJ, Yuasa HJ, Austin CJD, et al. 2009. Indoleamine 2,3-dioxygenase-2, a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol, 4, 467–471.
   Web of Science ®Google Scholar
• Ban Y, Chang Y, Dong B, et al. 2013. Indoleamine 2,3-dioxygenase levels at the normal and recurrent spontaneous abortion fetal-maternal interface. J Int Med Res, 41, 1139–1145.
   Web of Science ®Google Scholar
• Barrera D, Avila E, Días L. 2007. Papel inmunológico de la progesterone em el mantenimiento del embarazo. Revista de Investigación Clínica, 59, 139–145.
   PubMedGoogle Scholar
• Bartho JS, Wegmann TG. 1996. A Progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol, 31, 81–95.
   Google Scholar
• Bassal NK, Hughes BP, Costabile M. 2012. Arachidonic acid and its COX1/2 metabolites inhibit interferon-γ mediated induction of indoleamine-2,3 dioxygenase in THP-1 cells and human monocytes. Prostaglandins Leukotrienes Essent Fatty Acids, 87, 119–126.
   PubMed Web of Science ®Google Scholar
• Bubnoff D, Von Bieber T. 2012. The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy. Allergy, 67, 718–725.
   PubMed Web of Science ®Google Scholar
• Catani L, Sollazzo D, Trabanelli S, et al. 2013. Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia. Ann Hematol, 92, 67–68.
   PubMed Web of Science ®Google Scholar
• Harden JL, Egilmez NK. 2012. Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest, 41, 738–764.
   PubMed Web of Science ®Google Scholar
• Huang G, Zeng Y, Liang P, et al. 2012. Indoleamine 2,3-dioxygenase (IDO) downregulates the cell surface expression of the CD4 molecule. Int J Mol Sci, 13, 63–79.
   Web of Science ®Google Scholar
• Huang L, Baban B, Johnson BA, Mellor AL. 2010. Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege. Int Rev Immunol, 2, 133–155.
   Web of Science ®Google Scholar
• Hudi ICA, Pedersenb SB, Szekeres-Barthoc JDE, et al. 2015. Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth. J Reprod Immunol, 109, 36–40.
   PubMed Web of Science ®Google Scholar
• Jaronen M, Quintana JF. 2014. Immunological relevance of the coevolution of IDO1 and AHR. Front Immunol, 5, 1–7.
   PubMed Web of Science ®Google Scholar
• Kim S, Ha G, Kim H, Kang C. 2014. Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells. Immunol Invest, 43, 517–534.
   PubMed Web of Science ®Google Scholar
• Kudo Y, Boyd CAR, Spyropoulou I, et al. 2004. Indoleamine 2,3-dioxygenase: Distribution and function in the developing human placenta. J Reprod Immunol, 61, 87–98.
   PubMed Web of Science ®Google Scholar
• Liang J, Sun L, Wang Q, Hou Y. 2006. Progesterone regulates mouse dendritic cells differentiation and maturation. Int Immunopharmacol, 6, 830–838.
   PubMed Web of Science ®Google Scholar
• Lindström V, Aittoniemi J, Jylhävä J, et al. 2012. Indoleamine 2,3-dioxygenase activity and expression in patients with chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leukemia, 12, 363–365.
   PubMed Web of Science ®Google Scholar
• Mbongue MJ, Nicholas AD, Torrez TW, et al. 2015. The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity. Vaccines, 3, 703–729.
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. 2001. Tryptophan catabolism prevents maternal T cells from activating lethal antifetal immune responses. J Reprod Immunol, 52, 5–13.
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. 2004. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol, 4, 762–769.
   PubMed Web of Science ®Google Scholar
• Mesquita D, de Melo Cruvinel W, Araujo J, Pucci F, et al. 2011. Systemic lupus erythematosus exhibits a dynamic and continuum spectrum of effector/regulatory T cells. Scand J Rheumatol, 40, 41–50.
   PubMed Web of Science ®Google Scholar
• Moffett A, Loke C. 2006. Immunology of placentation in eutherian mammals. Nature reviews. Immunology, 6, 584–594.
   PubMed Web of Science ®Google Scholar
• Palafox D, Llorente L, Alberú J, et al. 2010. The role of indoleamine 2,3 dioxygenase in the induction of immune tolerance in organ transplantation. Transplant Rev, 24, 160–165.
   Web of Science ®Google Scholar
• Papamitsou T, Chatzistmatiou M, Grammatikopoulou D, et al. 2011. Low expression of progesterone receptor A in intermediate trophoblastos miscarriages. Histol Histopathol, 26, 609–614.
   PubMed Web of Science ®Google Scholar
• Rijk E, Esch EV, Flik G. 2002. Pregnancy dating in the rat: Placental morphology and maternal blood parameters. Toxicol Pathol, 30, 271–282.
   PubMed Web of Science ®Google Scholar
• Saito S, Nishikawa K, Morii T, et al. 1993. Cytokine production by CD16-CD56 bright natural killer cells in the human early pregnancy decidua. Int Immunol, 5, 559–563.
   PubMed Web of Science ®Google Scholar
• Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. 2009. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2. Blood, 113, 76–83.
   Web of Science ®Google Scholar
• Su L, Sun Y, Ma F, et al. 2009. Progesterone inhibitis toll-like receptor 4-mediated innate immune response in macrophages by suppressing NF-KappaB activation enhancing SOCS1 expressing. Immunol Lett, 125, 151–155.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Toné S, Takikawa O, et al. 2001. Expression of indoleamine 2,3-dioxigenase and tryptophan 2,3-dioxigenase in early concepti. Biochem J, 335, 425–429.
   Google Scholar
• Tenbrock KO, Tembrock K. 2011. Inflammatory cytokines in systemic Lupus Erythematosus. J Biomed and Biotechnol, 11, 1–14.
   Google Scholar
• Tizard IR. 2013. Veterinary Immunology, St Louis, Elsevier Saunders.
   Google Scholar
• Valente G, Ozmen L, Geuna M, et al. 1992. Distribution of interferon-gamma receptor in human tissues. Eur J Immunol, 22, 3–12.
   Web of Science ®Google Scholar
• Wira RC, Garcia MR, Patel MV. 2015. The role of sex hormones in immune protection of the female reproductive tract. Nat Rev Immunol, 15, 217–230.
   PubMed Web of Science ®Google Scholar
• Yasui H, Takai K, Yoshida R, Hayaishi O. 1986. Interferon y enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: It’s possible occurrence in cancer patients. Proc Natl Acad Sci USA, 83, 622–626.
   Web of Science ®Google Scholar
• Yingping X, Hao H, Chuanwei L, et al. 2011. Immunosuppressive effect of progesterone on dendritic cells in mice. J Reprod Immunol, 91, 17–23.
   PubMed Web of Science ®Google Scholar
• Yoshida R, Imanishi J, Oku T, et al. 1981. Induction of pulmonary indoleamine 2,3-dioxygenase by Interferon y. Proc Natl Acad Sci USA, 78, 129–132.
   PubMed Web of Science ®Google Scholar